Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults

Archives of Internal Medicine

Volumn 160, Issue 21, 2000, Pages 3234-3240

  Kaiser, L ^a   Keene, O N ^a   Hammond, J M J ^a   Elliott, M ^a   Hayden, F G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; ZANAMIVIR;

ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; HIGH RISK POPULATION; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SINUSITIS; TREATMENT OUTCOME;

EID: 0034722755     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.21.3234     Document Type: Article

References (25)

1. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion
2. Influenza A virus-induced acute otitis media
3. Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus
4. Nasal and otologic effects of experimental influenza A virus infection
5. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease
6. Time-series analysis of the relation between influenza virus and hospital admissions of the elderly in Ontario, Canada, for pneumonia, chronic lung disease, and congestive heart failure
7. Pneumonia in residents of long-term care facilities: Epidemiology, etiology, management, and prevention
8. Influenza-associated morbidity and mortality in young and middle-aged women
9. Amantadine, rimantadine, and related agents
10. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B infections
11. Efficacy and safety of neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infection
12. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections
13. The efficacy and safety of inhaled zanamivir in the treatment of influenza in otherwise healthy and 'high risk' individuals in North America
14. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor, zanamivir, in the treatment of influenza: European study
15. Statistical aspects of the analysis of data from retrospective studies of disease
16. The analysis of several 2 x 2 contigency tables
17. Effects of the neuraminidase inhibitor zanamivir on otologic manifestations of experimental human influenza
18. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis
19. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza
20. Efficacy and safety of oseltamivir in treatment of acute influenza: A randomized control trial
21. Local and systemic cytokine responses during experimental human influenza A virus infection
22. Nasal cytokine and chemokine responses in experimental influenza A virus infection: Results of a placebo-controlled trial of intravenous zanamivir treatment
23. Use of oral neuraminidase inhibitor oseltamivir in experimental human influenza: Randomized controlled trials for prevention and treatment
24. Evidence of cytokine mediation of disease expression in adults experimentally infected with influenza A virus